SCHEMBL100752

SCHEMBL100752

Cc1cc(C(=O)O)ccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 1/20 0.55
TDP1 Q9NUW8 4/20 0.55
GRM1 Q13255 2/20 0.55
MEN1 O00255 1/20 0.55
CYP1A2 P05177 1/20 0.55
KMT2A Q03164 1/20 0.55
TSHR P16473 4/20 0.52
HSD17B10 Q99714 3/20 0.52
MYC P01106 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PTPN7 P35236 1/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 6/20 0.50
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 5/20 0.49
GAA P10253 5/20 0.49
THRB P10828 3/20 0.49
HPGD P15428 3/20 0.49
GFER P55789 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30241864 1.00 CDC25B (0.55) CDC25BTDP1GRM1MEN1CYP1A2
Methane SCHEMBL27464390 0.98 CDC25B (0.53) CDC25BTDP1GRM1MEN1CYP1A2
Hydrochloric Acid SCHEMBL7347691 0.98 CDC25B (0.53) CDC25BTDP1GRM1MEN1CYP1A2
SCHEMBL3361348 0.94 TDP1 (0.54) CDC25BTDP1GRM1MEN1CYP1A2
SCHEMBL10434120 0.91 MAPT (0.52) CDC25BTDP1GRM1MEN1CYP1A2
SCHEMBL6866579 0.86 RARB (0.51) CDC25BTDP1GRM1MEN1CYP1A2
SCHEMBL436565 0.84 LMNA (0.56) TDP1TSHRHSD17B10LMNAMAPT
SCHEMBL13522875 0.84 ALDH1A1 (0.63) TDP1KMT2ATSHRHSD17B10LMNA
SCHEMBL377075 0.83 MAPT (0.73) CDC25BTDP1GRM1MEN1CYP1A2
SCHEMBL30508415 0.83 PRKCI (0.53) TDP1TSHRLMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036615-A Indazole hydrazide compound and preparation method and application thereof 南京农业大学 2026-05-15 CN claimed
CN-119192006-B Method for preparing 3-methyl-4-aminobenzoic acid by catalytic hydrogenation 河南羲和化工科技有限公司 2025-06-03 CN claimed
CN-119192006-A Method for preparing 3-methyl-4-aminobenzoic acid by catalytic hydrogenation 河南羲和化工科技有限公司 2024-12-27 CN claimed
CN-119069757-A Ion exchange membrane, preparation method thereof and all-iron flow battery 天津力神新能源科技有限公司 2024-12-03 CN claimed
CN-118344743-B High-viscosity modified asphalt and preparation method thereof 南京航空航天大学 2024-11-26 CN claimed
CN-118561677-A Synthesis method of 2-methyl-4-acetyl benzoic acid 丽珠集团福州福兴医药有限公司 2024-08-30 CN claimed
CN-118344743-A High-viscosity modified asphalt and preparation method thereof 南京航空航天大学 2024-07-16 CN claimed
CN-115466222-B Preparation method of telmisartan intermediate 江苏中邦制药有限公司 2024-06-04 CN claimed
CN-117924202-A Chrome-free tanning agent containing carboxylic acid sulfonate structure and preparation method thereof 浙江康诺和新材料有限公司 2024-04-26 CN claimed
CN-117623967-A Preparation method of telmisartan intermediate 3-methyl-4-aminobenzoic acid 迪嘉药业集团股份有限公司 2024-03-01 CN claimed
US-6531229-B1 An aqueous emulsion comprising: at least one resin, comprising at least one unit T, being: a A resin having the following formula (IV): MaDbTc(O1/2R)e(IV), wherein: which are identical or different, are C1-C8 alkyl groups, R is a RHODIA CHIMIE (FR) 2003-03-11 US claimed
WO-2002095393-A2 DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2002-11-28 WO claimed
EP-0907622-B1 AQUEOUS SILICON RESIN EMULSION FOR WATERPROOFING BUILDING MATERIALS RHODIA CHIMIE SA (FR) 2000-08-30 EP claimed
US-5866608-A AROMATIC COMPOUNDS BIORESEARCH, INC. (US) 1999-02-02 US claimed
EP-0572560-A4 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. SHAPIRO HOWARD K (US) 1995-04-26 EP claimed
EP-0572560-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO, Howard, K. (US) 1993-12-08 EP claimed
EP-0571095-A2 Polyester copolymer and process for the production of the same BRIDGESTONE CORPORATION (JP) 1993-11-24 EP claimed
WO-1992014456-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO HOWARD K (US) 1992-09-03 WO claimed
US-4356277-A Reaction products of a polyglycidyl ether of a polyphenol and an amino acid and aqueous solubilized products therefrom PPG INDUSTRIES, INC. (US) 1982-10-26 US claimed
US-4299747-A LININGS PPG INDUSTRIES, INC. (US) 1981-11-10 US claimed